Logo image of ACO-X.CA

ATCO LTD -CLASS I (ACO-X.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:ACO-X - CA0467894006 - Common Stock

56.42 CAD
+0.24 (+0.43%)
Last: 1/7/2026, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, ACO-X scores 5 out of 10 in our fundamental rating. ACO-X was compared to 20 industry peers in the Multi-Utilities industry. ACO-X has an average financial health and profitability rating. ACO-X has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ACO-X had positive earnings in the past year.
ACO-X had a positive operating cash flow in the past year.
Each year in the past 5 years ACO-X has been profitable.
In the past 5 years ACO-X always reported a positive cash flow from operatings.
ACO-X.CA Yearly Net Income VS EBIT VS OCF VS FCFACO-X.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

ACO-X has a Return On Assets of 1.55%. This is comparable to the rest of the industry: ACO-X outperforms 45.00% of its industry peers.
The Return On Equity of ACO-X (9.08%) is better than 90.00% of its industry peers.
ACO-X has a worse Return On Invested Capital (3.73%) than 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ACO-X is in line with the industry average of 3.74%.
Industry RankSector Rank
ROA 1.55%
ROE 9.08%
ROIC 3.73%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ACO-X.CA Yearly ROA, ROE, ROICACO-X.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ACO-X has a Profit Margin (8.38%) which is in line with its industry peers.
In the last couple of years the Profit Margin of ACO-X has declined.
ACO-X has a Operating Margin of 24.56%. This is comparable to the rest of the industry: ACO-X outperforms 45.00% of its industry peers.
ACO-X's Operating Margin has declined in the last couple of years.
ACO-X has a Gross Margin (74.90%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ACO-X has remained more or less at the same level.
Industry RankSector Rank
OM 24.56%
PM (TTM) 8.38%
GM 74.9%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
ACO-X.CA Yearly Profit, Operating, Gross MarginsACO-X.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

ACO-X has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ACO-X remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ACO-X has less shares outstanding
The debt/assets ratio for ACO-X is higher compared to a year ago.
ACO-X.CA Yearly Shares OutstandingACO-X.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ACO-X.CA Yearly Total Debt VS Total AssetsACO-X.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

Based on the Altman-Z score of 0.78, we must say that ACO-X is in the distress zone and has some risk of bankruptcy.
ACO-X has a better Altman-Z score (0.78) than 85.00% of its industry peers.
The Debt to FCF ratio of ACO-X is 27.90, which is on the high side as it means it would take ACO-X, 27.90 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 27.90, ACO-X belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 2.64 is on the high side and indicates that ACO-X has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.64, ACO-X is doing worse than 70.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF 27.9
Altman-Z 0.78
ROIC/WACC0.73
WACC5.09%
ACO-X.CA Yearly LT Debt VS Equity VS FCFACO-X.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.81 indicates that ACO-X should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.81, ACO-X belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
ACO-X has a Quick Ratio of 1.66. This is a normal value and indicates that ACO-X is financially healthy and should not expect problems in meeting its short term obligations.
ACO-X has a better Quick ratio (1.66) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.66
ACO-X.CA Yearly Current Assets VS Current LiabilitesACO-X.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

ACO-X shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.19%, which is quite good.
Measured over the past 5 years, ACO-X shows a small growth in Earnings Per Share. The EPS has been growing by 6.10% on average per year.
Looking at the last year, ACO-X shows a small growth in Revenue. The Revenue has grown by 7.75% in the last year.
Measured over the past years, ACO-X shows a small growth in Revenue. The Revenue has been growing by 0.98% on average per year.
EPS 1Y (TTM)10.19%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%13.58%
Revenue 1Y (TTM)7.75%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%6.09%

3.2 Future

Based on estimates for the next years, ACO-X will show a small growth in Earnings Per Share. The EPS will grow by 4.90% on average per year.
ACO-X is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.20% yearly.
EPS Next Y8.92%
EPS Next 2Y4.96%
EPS Next 3Y4.9%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y1.49%
Revenue Next 3Y2.2%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ACO-X.CA Yearly Revenue VS EstimatesACO-X.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
ACO-X.CA Yearly EPS VS EstimatesACO-X.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.43, ACO-X is valued correctly.
ACO-X's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.92. ACO-X is valued rather cheaply when compared to this.
ACO-X is valuated reasonably with a Price/Forward Earnings ratio of 11.94.
ACO-X's Price/Forward Earnings ratio is in line with the industry average.
ACO-X is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.43
Fwd PE 11.94
ACO-X.CA Price Earnings VS Forward Price EarningsACO-X.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ACO-X's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ACO-X is cheaper than 75.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACO-X indicates a somewhat cheap valuation: ACO-X is cheaper than 65.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.63
EV/EBITDA 8.37
ACO-X.CA Per share dataACO-X.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.39
PEG (5Y)2.04
EPS Next 2Y4.96%
EPS Next 3Y4.9%

6

5. Dividend

5.1 Amount

ACO-X has a Yearly Dividend Yield of 3.58%. Purely for dividend investing, there may be better candidates out there.
With a Dividend Yield of 3.58, ACO-X pays less dividend than the industry average, which is at 4.53. 95.00% of the companies listed in the same industry pay a better dividend than ACO-X!
Compared to an average S&P500 Dividend Yield of 1.94, ACO-X pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.58%

5.2 History

The dividend of ACO-X has a limited annual growth rate of 3.93%.
ACO-X has paid a dividend for at least 10 years, which is a reliable track record.
ACO-X has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.93%
Div Incr Years31
Div Non Decr Years34
ACO-X.CA Yearly Dividends per shareACO-X.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ACO-X pays out 52.20% of its income as dividend. This is a bit on the high side, but may be sustainable.
ACO-X's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP52.2%
EPS Next 2Y4.96%
EPS Next 3Y4.9%
ACO-X.CA Yearly Income VS Free CF VS DividendACO-X.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M
ACO-X.CA Dividend Payout.ACO-X.CA Dividend Payout, showing the Payout Ratio.ACO-X.CA Dividend Payout.PayoutRetained Earnings

ATCO LTD -CLASS I

TSX:ACO-X (1/7/2026, 7:00:00 PM)

56.42

+0.24 (+0.43%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)02-25 2026-02-25
Inst Owners27.8%
Inst Owner ChangeN/A
Ins Owners0.69%
Ins Owner ChangeN/A
Market Cap6.32B
Revenue(TTM)5.14B
Net Income(TTM)431.00M
Analysts78.57
Price Target61.49 (8.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.58%
Yearly Dividend1.96
Dividend Growth(5Y)3.93%
DP52.2%
Div Incr Years31
Div Non Decr Years34
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.14%
Min EPS beat(2)-3.78%
Max EPS beat(2)8.05%
EPS beat(4)3
Avg EPS beat(4)2.22%
Min EPS beat(4)-3.78%
Max EPS beat(4)8.05%
EPS beat(8)7
Avg EPS beat(8)4.37%
EPS beat(12)9
Avg EPS beat(12)2.66%
EPS beat(16)12
Avg EPS beat(16)4.06%
Revenue beat(2)0
Avg Revenue beat(2)-9.84%
Min Revenue beat(2)-17.7%
Max Revenue beat(2)-1.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.73%
Min Revenue beat(4)-18.52%
Max Revenue beat(4)-0.7%
Revenue beat(8)0
Avg Revenue beat(8)-11.91%
Revenue beat(12)0
Avg Revenue beat(12)-10.29%
Revenue beat(16)1
Avg Revenue beat(16)-9.26%
PT rev (1m)4.54%
PT rev (3m)7.65%
EPS NQ rev (1m)-0.47%
EPS NQ rev (3m)-0.2%
EPS NY rev (1m)-0.34%
EPS NY rev (3m)1.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)5.26%
Revenue NY rev (3m)0.61%
Valuation
Industry RankSector Rank
PE 12.43
Fwd PE 11.94
P/S 1.23
P/FCF 13.63
P/OCF 2.59
P/B 1.33
P/tB 1.87
EV/EBITDA 8.37
EPS(TTM)4.54
EY8.05%
EPS(NY)4.73
Fwd EY8.38%
FCF(TTM)4.14
FCFY7.34%
OCF(TTM)21.76
OCFY38.56%
SpS45.88
BVpS42.35
TBVpS30.16
PEG (NY)1.39
PEG (5Y)2.04
Graham Number65.77
Profitability
Industry RankSector Rank
ROA 1.55%
ROE 9.08%
ROCE 4.79%
ROIC 3.73%
ROICexc 3.92%
ROICexgc 4.15%
OM 24.56%
PM (TTM) 8.38%
GM 74.9%
FCFM 9.02%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ROICexc(3y)4.06%
ROICexc(5y)3.97%
ROICexgc(3y)4.27%
ROICexgc(5y)4.16%
ROCE(3y)5.04%
ROCE(5y)4.9%
ROICexgc growth 3Y1.58%
ROICexgc growth 5Y-6.25%
ROICexc growth 3Y1.11%
ROICexc growth 5Y-6.55%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
F-Score7
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF 27.9
Debt/EBITDA 5.96
Cap/Depr 234.56%
Cap/Sales 38.4%
Interest Coverage 2.33
Cash Conversion 115.87%
Profit Quality 107.66%
Current Ratio 1.81
Quick Ratio 1.66
Altman-Z 0.78
F-Score7
WACC5.09%
ROIC/WACC0.73
Cap/Depr(3y)212.07%
Cap/Depr(5y)195.52%
Cap/Sales(3y)33.77%
Cap/Sales(5y)31.75%
Profit Quality(3y)134.57%
Profit Quality(5y)187.54%
High Growth Momentum
Growth
EPS 1Y (TTM)10.19%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%13.58%
EPS Next Y8.92%
EPS Next 2Y4.96%
EPS Next 3Y4.9%
EPS Next 5YN/A
Revenue 1Y (TTM)7.75%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%6.09%
Revenue Next Year0%
Revenue Next 2Y1.49%
Revenue Next 3Y2.2%
Revenue Next 5YN/A
EBIT growth 1Y25.67%
EBIT growth 3Y7.57%
EBIT growth 5Y-2.22%
EBIT Next Year433.88%
EBIT Next 3Y81.02%
EBIT Next 5YN/A
FCF growth 1Y1.09%
FCF growth 3Y-8.79%
FCF growth 5Y2.94%
OCF growth 1Y16.42%
OCF growth 3Y5.63%
OCF growth 5Y7.34%

ATCO LTD -CLASS I / ACO-X.CA FAQ

What is the ChartMill fundamental rating of ATCO LTD -CLASS I (ACO-X.CA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ACO-X.CA.


What is the valuation status of ATCO LTD -CLASS I (ACO-X.CA) stock?

ChartMill assigns a valuation rating of 5 / 10 to ATCO LTD -CLASS I (ACO-X.CA). This can be considered as Fairly Valued.


What is the profitability of ACO-X stock?

ATCO LTD -CLASS I (ACO-X.CA) has a profitability rating of 4 / 10.


Can you provide the financial health for ACO-X stock?

The financial health rating of ATCO LTD -CLASS I (ACO-X.CA) is 5 / 10.


What is the expected EPS growth for ATCO LTD -CLASS I (ACO-X.CA) stock?

The Earnings per Share (EPS) of ATCO LTD -CLASS I (ACO-X.CA) is expected to grow by 8.92% in the next year.